No Data
No Data
12 Health Care Stocks Moving In Wednesday's Intraday Session
Relmada Therapeutics To Present NDV-01 Data at AUA2025
Relmada Therapeutics Reports 2024 Financial Results and Strategic Progress
Earnings Call Summary | Relmada Therapeutics(RLMD.US) Q4 2024 Earnings Conference
Relmada Outlines Plans for NDV-01 Phase 2 Results Presentation and Sepranolone Development
RELMADA THERAPEUTICS Earnings Results: $RLMD Reports Quarterly Earnings